Log in to save to my catalogue

Time to relapse in chronic lymphocytic leukemia and DNA-methylation-based biological age

Time to relapse in chronic lymphocytic leukemia and DNA-methylation-based biological age

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_13f798d1cf85400a900e08a789e82a78

Time to relapse in chronic lymphocytic leukemia and DNA-methylation-based biological age

About this item

Full title

Time to relapse in chronic lymphocytic leukemia and DNA-methylation-based biological age

Publisher

Germany: BioMed Central Ltd

Journal title

Clinical epigenetics, 2023-05, Vol.15 (1), p.81-81, Article 81

Language

English

Formats

Publication information

Publisher

Germany: BioMed Central Ltd

More information

Scope and Contents

Contents

Chronic lymphocytic leukemia (CLL) is a mature B cell neoplasm with a predilection for older individuals. While previous studies have identified epigenetic signatures associated with CLL, whether age-related DNA methylation changes modulate CLL relapse remains elusive. In this study, we examined the association between epigenetic age acceleration a...

Alternative Titles

Full title

Time to relapse in chronic lymphocytic leukemia and DNA-methylation-based biological age

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_13f798d1cf85400a900e08a789e82a78

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_13f798d1cf85400a900e08a789e82a78

Other Identifiers

ISSN

1868-7083,1868-7075

E-ISSN

1868-7083,1868-7075

DOI

10.1186/s13148-023-01496-8

How to access this item